Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.150
+0.060 (2.87%)
At close: Aug 3, 2026, 4:00 PM EDT
2.130
-0.020 (-0.93%)
After-hours: Aug 3, 2026, 7:34 PM EDT
Nkarta Market Cap
Nkarta has a market cap or net worth of $153.82 million as of August 3, 2026. Its market cap has increased by 2.26% in one year.
Market Cap
153.82M
Enterprise Value
-1.61M
1-Year Change
2.26%
Ranking
Category
Stock Price
$2.15
ChartMarket Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $153.82M, a decrease of -89.49%. That is a compound annual growth rate of -31.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 153.82M | 17.06% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 154.38M |
| OnKure Therapeutics | 154.31M |
| YD Bio | 152.59M |
| Milestone Pharmaceuticals | 151.02M |
| Korro Bio | 149.56M |
| Canton Strategic Holdings | 148.85M |
| Entera Bio | 147.38M |
| Cibus | 147.32M |